Introduction
Cancer in girls and young women has become increasingly curable over the past couple of decades (Donnez and Dolmans, 2013) . However, while treatments are often highly effective for the underlying pathology, they can induce premature ovarian failure, leading to subsequent infertility (Donnez et al., 2006) . For patients undergoing these gonadotoxic treatments, several fertility preservation options are available: ovarian transposition, embryo cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation (Donnez et al., 2006) , the latter being the only alternative for prepubertal girls and patients who cannot delay treatment (Wallace et al., 2014) . Although more than 100 live births have been reported to date Jensen et al., 2016) , early post-transplantation hypoxia remains an issue because of its negative impact on follicle survival (Van Eyck et al., 2009 , 2010 , with follicle loss of >50% often observed during the first few days post-grafting (Baird et al., 1999; Kim, 2006) .
Increasing vascularization in grafted tissue is crucial, since it has been found to enhance follicle survival in mice (Shikanov et al., 2011) and in human ovarian tissue (Xia et al., 2015) . A number of attempts have, therefore, been made to improve follicle survival rates in mouse models using both murine and human ovarian tissue (Mahmoodi et al., 2014 (Mahmoodi et al., , 2015 Zhang et al., 2015) , with a view to increasing the efficiency of ovarian tissue transplantation.
Adipose tissue-derived stem cells (ASCs), first described by Zuk et al. (2001) , constitute a population of mesenchymal stem cells (MSCs) with multiple mesodermal lineage capacities. The angiogenic potential of ASCs has been reported in a number of studies (De Francesco et al., 2009; Veriter et al., 2014) , confirming their capacity to boost angiogenesis by secreting growth factors and allowing their differentiation into vessels (Moon et al., 2006; Lafosse et al., 2015) . One group recently demonstrated that a combination of ASCs and adipose-derived microvascular endothelial cells embedded in fibrin and delivered in poly L-lactic acid/poly lactic-co-glycolic acid scaffolds favors vessel formation in vitro (before grafting) and enhances vascularization in vivo in the context of bioengineered muscle flaps for large soft tissue defects (Freiman et al., 2016 (Freiman et al., , 2017 .
The aim of this study was to evaluate the role of ASCs in the angiogenic process and vascularization in a fibrin scaffold through ASC endothelial differentiation and proangiogenic behavior. We compared two different ASC concentrations delivered inside a fibrin scaffold grafted to mouse peritoneum for three different short-term periods, aiming to identify the best concentration of cells and most appropriate preparation time needed to optimize the ovarian tissue grafting site.
Materials and Methods

Experimental design
A total of 22 severe combined immunodeficient (SCID) mice were used for this experiment. In total, 16 mice (eight per group) were intraperitoneally grafted with a fibrin scaffold loaded with two different ASC concentrations (either 1.5.10 5 or 1.5.10 6 cells) and lithium phthalocyanine (LiPc) crystals (Dartmouth Medical School, Hanover, NH, USA). LiPc was used as an oxygen-sensitive paramagnetic probe, whose line-width is a linear function of partial pressure of oxygen (pO 2 ), and independent of local metabolic processes, other paramagnetic species, and pH. No toxic effect was detected in xenografted human ovarian tissue in a previous study by our group (Van Eyck et al., 2009) . Six mice were grafted with an empty fibrin (EF) implant containing only LiPc crystals and served as controls (Fig. 1) . Levels of pO 2 in implants were monitored in vivo on post-grafting Days 3 (n = 14), 7 (n = 16) and 14 (n = 8) by electron paramagnetic resonance oximetry (EPR), as previously described (Van Eyck et al., 2009) . Two or three mice from each group were killed after each measurement and implants were collected for histology and immunohistochemistry (IHC) (Fig. 1) .
Adipose tissue-derived stem cells
Human ASCs from female donors were commercially acquired (STEMPRO ® human ASCs, Invitrogen, Carlsbad, CA, USA). These cells were shown to express a flow cytometry cell surface protein profile positive for CD29, CD44, CD73, CD90, CD105 and CD166 (>95%), but negative for CD34, CD14, CD31, CD45 and Lin1 (<2%), consistent with specific surface antigen criteria that characterize MSCs (Dominici et al., 2006) . ASCs were cultured and expanded at 37°C in 5% CO 2 /95% air in MesenPRO RS medium (Gibco, Glasgow, Scotland), supplemented with 2% v/v MesenPRO RS growth supplement (Gibco), 1% v/v L-glutamine (Gibco) and 1% v/v penicillin-streptomycin (Gibco). Cultures were washed in phosphate-buffered saline (PBS, Gibco) and passaged by enzymatic digestion using Accutase (Sigma-Aldrich, St. Louis, Missouri, USA) after achieving a density of 80-90%. Repeated viability tests with addition of trypan blue solution (Sigma-Aldrich) showed very high (~95%) viability. Cells used in this study were all between passages 2 and 5.
Incorporation of cells into fibrin implants and LiPc crystal insertion
Fibrin scaffolds were assembled as previously described (Chiti et al., 2016) , with volume and concentrations of fibrinogen and thrombin determined according to preliminary studies. A volume of 22.5 μL of fibrinogen solution (50 mg/mL) (Tisseel, Baxter, Belgium) was placed in 8-well glass chamber slides. One-hundred and fifty thousand ASCs (low concentration [L-ASCs] (Germain et al., 2015) suspended in 15 μL of growth medium were successively added to the fibrinogen, while 15 μl of growth medium without cells was added to the controls. The fibrinogen solution containing the medium with or without cells was mixed with thrombin (50 IU/mL) at a v:v ratio of 1:1. Two to three LiPc crystals were then placed inside the fibrin scaffolds using small forceps, prior to incubation for 15-30 min at 37°C for fibrin polymerization. The implants were then gently detached for xenografting.
Ethical approval
Animal welfare guidelines were approved by the Committee on Animal Research of the Université Catholique de Louvain.
Transplantation procedure
A total of 22 female SCID mice (Charles River Laboratories, France) were used for this study. Satisfactory housing and breeding conditions, anesthesia and analgesia were achieved as previously reported (Nisolle et al., 2000) . A horizontal incision was made in the skin and abdominal wall to attach the implants to the lower third of the parietal peritoneum. The inner peritoneal surface was scratched with a scalpel (Luyckx et al., 2014) , before gently suturing the scaffold with 2-3 cardinal stitches using 7/0 Prolene. Each mouse was grafted with a scaffold containing H-ASCs or L-ASCs plus LiPc crystals (n = 16). The remaining control mice (n = 6) were grafted with EF implants containing only LiPc crystals. The abdominal wall and skin were then closed.
EPR oximetry
EPR oximetry is a sensitive, non-invasive method that allows repeated in vivo measurements of tissue pO 2 with an accuracy of <1 mmHg (Van Eyck et al., 2009) . The extent of the effect is related to the amount of oxygen present in the environment of the paramagnetic materials (Khan et al., 2007) . EPR spectra were recorded using an EPR spectrometer (Clin-EPR, Dartmouth EPR Center, Lebanon, NH, USA) with a low-frequency microwave bridge operating at 1.15 GHz and an extended loop resonator. Typical spectrometer parameters included scan range of 0.25 mT, scan time of 3 s, 1024 points/scan, modulation amplitude of 0.01 mT, incident microwave power of 0.794 mW, modulation frequency of 21.3 kHz and accumulation of 20-30 scans per measurement. For pO 2 measurements, the mice were anesthetized using isoflurane (3% for induction, 2% for maintenance) with strictly controlled air-breathing movements. Body temperature was maintained by use of a heated water blanket. The mice were positioned in the center of the magnet so that the graft site containing LiPc crystals was directly under the extended loop resonator. EPR line-widths (LW) were converted to pO 2 by means of a calibration curve determined for the LiPc crystals used in this study. The pO 2 was calculated using the following equation:
Monitoring of pO 2 was performed on post-grafting Days 3, 7 and 14. After exposure to ambient air-breathing conditions (21% O 2 ), negative controls were applied to confirm the oxygen sensitivity of the paramagnetic probes for each mouse. For these negative controls, pO 2 levels were measured reproducibly 15 min after the mice were euthanized by cervical dislocation (0% O 2 ).
Histological and immunohistochemical staining
All recovered samples were fixed in 4% formaldehyde, embedded in paraffin and serially sectioned (5-μm-thick coronal sections from the fibrin component to the peritoneum). The slides were stained with hematoxylin-eosin (HE) (Merck, Darmstadt, Germany) for histological evaluation, digitized after Figure 1 Twenty-two SCID mice were intraperitoneally grafted with a fibrin scaffold loaded with two different adipose tissue-derived stem cells (ASC) concentrations (low 1.5 × 10 5 and high 1.5 × 10 6 cells) and lithium phthalocyanine (LiPc) crystals, while empty fibrin (EF) implants containing only LiPc were grafted to controls. Electron paramagnetic resonance (EPR) oximetry was performed on Days 3, 7 and 14 before euthanizing the animals for histology and immunohistochemical assessments in a staggered fashion. Vim: anti-human vimentin.
immunolabeling using the Mirax Scan system (Zeiss, Germany), and analyzed using Mirax Viewer or ImageJ (http://rsb.info.nih.gov/ij/) software. To assess fibrin resorption kinetics, the volume of the implants was investigated by applying the Cavalieri principle. Serial HE-stained sections were evaluated every 60 μm using ×4 magnification, and analyzed with ImageJ to count the points superimposed on fibrin implant images. Total volume (mm 3 ) was estimated using the following equation:
where
is the total number of points, a(P) is the corresponding area of each point and t is the distance between sampled sections and section thickness (Mahmoodi et al., 2014) .
Identification and proliferation of implanted ASCs
Vimentin, a cytoskeletal protein, is a marker of cells of mesenchymal origin. In order to label and identify grafted ASCs and quantify the number of proliferating ASCs, anti-human vimentin and Ki67 immunostaining respectively were performed, as previously reported (Soares et al., 2015) . Primary antibodies used were mouse anti-human vimentin (1:1000 dilution, clone V9, 0725, Dako) and mouse anti-human Ki67 (1:100 dilution, clone MIB, mAb ref.: M7240, Dako). The secondary antibody used was Envision goat antimouse IgG (1:2 dilution, Dako). For negative controls, slides were incubated without the primary antibodies. One section per implant was stained and analyzed for vimentin and three for Ki67. After delimiting the implant, the proportion of vimentin-positive surface area was calculated, as well as the number of proliferating cells.
Implant vascularization
Vessels of both murine and human origin were investigated by double CD34 immunolabeling, staining endothelial cell membranes, as detailed in an earlier publication (Soares et al., 2015) . Antibodies used were rat antimouse CD34 (1:100 dilution, clone MEC 14.7, HM 1015; Hycult Biotechnology, Uden, the Netherlands) and rabbit anti-rat coupled to biotin, followed by mouse anti-human CD34 (1:500 dilution, clone QBEnd/ 10, CM084B; Biocare Medical, Concord, CA) and goat anti-mouse (1:300 dilution; Jackson Immunoresearch, Suffolk, UK). Nuclei were counterstained with hematoxylin. For negative controls, one slide was incubated without the primary antibodies. Six sections per graft were analyzed after dividing the implants into two distinct areas in order to further identify the optimal surface for ovarian tissue grafting: (i) the area of the implant in direct contact with the peritoneum and delimited by the stitches, namely the contact zone (CZ) or (ii) the area corresponding to non-resorbed fibrin. Vessel sections were considered positive when at least one endothelial cell was stained. Results are expressed as the percentage of surface area covered with vessels, or endothelial area relative to total section area.
Statistical analysis
Results are expressed as means ± SEM. GraphPad Prism, version 7.00 for Windows (GraphPad Software, La Jolla, CA, USA), was used for statistical analyses. Two-way ANOVA followed by Tukey's multiple comparison test and uncorrected Fisher's LSD test were applied where appropriate. A P-value <0.5 was considered statistically significant. Linear regression was performed to correlate endothelial area with pO 2 values.
Results
EPR oximetry
Use of EPR in a fibrin scaffold
The responsiveness of LiPc crystals to pO 2 variations may be lost over time depending on implantation site. For this reason, and given the fact that no information is available on LiPc stability in fibrin scaffolds, negative control measurements were included to ascertain the responsiveness of the paramagnetic probe to pO 2 variations.
Results of negative controls confirmed the responsiveness of LiPc to pO 2 , following clear changes in pO 2 conditions. A significant decrease in pO 2 levels was observed 15 min after euthanasia compared to ambient air-breathing conditions (mean pO 2 ± SD: 8.66 ± 1.38 mmHg and 3.42 ± 0.52 mmHg [P = 0.0049] for ambient air-breathing conditions [21% O 2 ] and post-mortem measurements [0% O 2 ], respectively).
pO 2 monitoring in fibrin implants
Levels of pO 2 were monitored and analyzed in 20 of the 22 operated mice (Fig. 2) . Two mice were excluded because no measurable LiPc values were obtained, suggesting spatial dispersion or disruption of the crystals, which could create signal interference and loss of sensitivity in measurements . Indeed, one of the recovered implants had LiPc crystals dispersed throughout the fibrin scaffold, and the other showed LiPc crystals located in fatty tissue surrounding the grafting site. A significant increase in pO 2 was observed in all groups between Days 3 and 7 (P = 0.0008), but no significant difference was found from Days 7 to 14. However, ASC-loaded implants showed a tendency towards increased pO 2 levels from 
Macroscopic, histological and immunohistochemical evaluation
Macroscopic evaluation
The implant recovery rate was 100%. On Day 3, EF implants had a white appearance and adhered to the peritoneum only by means of stitches, as fibrin could be easily detached from the peritoneum in central areas where stitches had not been placed. ASC-loaded implants (L-ASCs and H-ASCs), however, were more adherent to the peritoneum. By Day 7 and up to Day 14, all implants were adherent to the peritoneum across the entire fibrin surface and had a more transparent appearance in the H-ASC and L-ASC groups than in the EF group.
Microscopic evaluation
Implant resorption was assessed by estimating the volume of retrieved implants in HE-stained sections (Fig. 3A-C) . Implants showed progressive fibrin resorption over time in all groups (Table 1) , but no difference between groups at any time point. At histological analysis, necrotic-like areas were observed on HE slides, consisting of intensely basophilic areas in the fibrin that reached 18% of implants in the EF group (Fig. 3A) , but accounted for <2% of implant surface area in the H-ASC and L-ASC groups (Fig. 3B, C) ( Table 1) .
ASC identification and proliferation in ASC-loaded implants
Anti-human vimentin IHC (Fig. 3D) showed a tendency towards increased area occupied by ASCs over time with both ASC concentrations. The largest area occupied by human vimentin-positive ASCs was found in the H-ASC group on Day 7 (mean percentage: area 16.23% of the implant) ( Table 1) .
Proliferation of grafted human ASCs evaluated by anti-human Ki67 IHC (Fig. 3E ) appeared to decrease in proliferating ASCs in the H-ASC group (number of Ki67-positive cells/mm 2 ) from Days 3 to 14, while the L-ASC group showed no significant difference in proliferation over time (Table 1) .
Implant vascularization
Regarding non-resorbed fibrin area vascularization, human and murine CD34-positive vessels evaluated by endothelial area (Fig. 4A-F ) showed a significant increase over time in the H-ASC group (P = 0.005), but not in the L-ASC group, where no significant difference was observed (P = 0.34) (Fig. 5A ). In terms of CZ vascularization, there was an apparent increase in total endothelial area between Days 3 and 7 in all groups, but only the L-ASC group showed a significant increase between Days 7 and 14 (L-ASCs: P = 0.01) (Fig. 5A) . No difference was noted between groups at any individual time point.
Human CD34-positive vessels were detected in both CZ and nonresorbed fibrin areas of implants in the H-ASC and L-ASC groups (Fig. 5B) . In terms of non-resorbed fibrin area, there was a significant increase from Days 7 to 14 in human endothelial area in the H-ASC group (P = 0.0006). A significant difference was found on Day 14 between the L-ASC group and the H-ASC group (P = 0.0049). The largest human CD34-positive surface area was observed in the H-ASC group. With respect to CZ area, there was no significant difference in human endothelial area over time, nor between groups. A positive correlation was found when comparing total endothelial area with pO 2 values obtained by EPR oximetry (r = 0.6506, P = 0.0019) (Fig. 5C ).
Discussion
The present study was designed to evaluate the impact of preparing a peritoneal grafting site using two different concentrations of ASCs embedded in fibrin implants, with a view to potential future application in ovarian tissue transplantation. To our knowledge, this is the first time that EPR oximetry has been applied to investigate in vivo oxygenation kinetics inside a fibrin scaffold implanted in the peritoneal cavity with or without ASCs. This technique enabled us to establish how a fibrin implant becomes vascularized over time when grafted to the peritoneum of SCID mice. In a comparison of oxygenation kinetics, we found a similar tendency in all groups, regardless of the presence of ASCs, showing an increase over the first 7 days and no difference up to Day 14. Our oxygenation curve exhibited the same pattern as observed previously (Van Eyck et al., 2009) in ovarian tissue, with values climbing over the course of the first 10 days. The increase in pO 2 suggests an active process of implant vascularization, resulting in subsequently improved oxygenation. Progressive vascularization of the fibrin implants was evaluated by immunolabeling the CD34 antigen of both human and murine origin. Results obtained for total endothelial area showed that the area in direct contact with the peritoneum (CZ), which is the first to be reached by host vessels, has a larger vascularized surface. We observed not only host vessels contributing to the vascularization of fibrin implants, but also newly formed human vessels, as CD34-positive human vessels were found in both areas of the implant. Areas covered with human Our findings suggest that the number of cells used could play a role and may well be important for the formation of human neovessels (Rubina et al., 2009) corroborated previous findings with ASCs (Chung et al., 2015) and mesenchymal precursor cells (Koike et al., 2004) . One of the main mechanisms that may explain our findings is differentiation of MSCs into endothelial cells and pericytes, thereby providing the necessary cellular components to stabilize newly formed vessels (Au et al., 2008; De Francesco et al., 2009; Mendel et al., 2013) . ASC differentiation is also supported by the significant decrease in cell proliferation in the H-ASC group over time, suggesting that ASCs may undergo a proliferation/differentiation switch (Garcia et al., 1999; Conti et al., 2001; Chen et al., 2006) .
According to the literature, MSCs promote vascular formation through secretion of growth factors such as VEGF, FGF2, HGF, bFGF, PDGFB, TGFβ and angiogenin among others, mainly secreted when exposed to hypoxia (Rubina et al., 2009) , which have proven to promote angiogenesis (Chung et al., 2015; Xia et al., 2015) . This important mechanism could also explain the differences observed in our study.
ASC-loaded fibrin scaffolds had a better macroscopic and microscopic appearance, showing significantly fewer necrotic-like areas in HE-stained sections than implants without ASCs. The low degree of this inflammatory pattern in implants containing ASCs suggests their protective role, not witnessed in implants without cells. ASCs may play a part in modulating host activation with respect to the graft and inflammation, as it is known that they can modify and inhibit the innate immune response (Castro-Manrreza and Montesinos, 2015) .
Regarding the presence of grafted cells inside the fibrin implants, it appears that a large number of ASCs remained in the grafting site, as they were still detectable by anti-human vimentin IHC and accounted for up to 16% of implants by Day 14 in our model. This was not the case in other studies, where ASCs that were intravenously injected or locally transplanted sustained massive cell loss (Sun et al., 2013; Su et al., 2016) . Based on these findings, we could hypothesize that ASCs may not undergo solely endothelial differentiation, as the percentage of surface area covered with human CD34-positive vessels reached 1% of implants in the H-ASC group. The difference in observed percentages not only suggests differentiation into other cell types of mesenchymal lineage, such as fibroblasts (Hong et al., 2013) , but also retention of stemness after 14 days.
Subjecting patients to a two-step procedure for fertility restoration, using ASCs in a first step to prepare the ovarian tissue transplantation site, may be justified if a significant increase in follicle survival rates can be achieved. Indeed, the first live birth from human ovarian tissue cryopreservation and transplantation published by Donnez et al. (2004) was obtained by means of two surgical procedures. The first involved creation of a peritoneal window and coagulation of its edges to improve neoangiogenesis. After 7 days, ovarian tissue was transplanted to this specially created peritoneal window, where an extensive vascular network was visible (Donnez et al., 2004) .
We chose ASCs for our model because of their easy harvesting in large numbers using minimally invasive procedures like liposuction. However, there is also evidence that ASCs retain their phenotypic and functional characteristics after long-term cryopreservation (Yong et al., 2015) , which would allow cell harvesting as soon as human ovarian tissue is retrieved from patients. Although commercial ASCs were used for this study, autologous ASCs would be employed for clinical applications.
Another supporting argument is the number of existing therapies already using ASCs in a variety of fields, such as rheumatology (Garimella et al., 2015) , gastroenterology (Lee et al., 2013) , neurology (Staff et al., 2016) , and plastic and reconstructive surgery for chronic wound healing and bone regeneration . Moreover, numerous clinical trials (phases I-II and III) assessing ASC safety and efficacy are currently being conducted or have already been completed (https://clinicaltrials.gov: 214 ongoing, 57 completed), testifying to the widespread interest in the potential of these cells.
This study could serve as a starting point for further investigations to determine the kinetics of oxygen diffusion in fibrin-based biomaterials, as no studies have yet been published on the influence of biophysical properties of different fibrin formulations and their impact on the ability of oxygen molecules to navigate throughout the scaffold.
We believe that our proposed preparation of the grafting site would not only benefit ovarian tissue transplantation, but also other experimental avascular grafting procedures, such as the artificial ovary made from fibrin formulations (Chiti et al., 2016 (Chiti et al., , 2017 .
Conclusion
We investigated and demonstrated the effectiveness of EPR oximetry to evaluate the oxygen environment in a fibrin scaffold transplanted to mouse peritoneum. We observed that pO 2 values obtained by EPR correlate strongly with implant vascularization, confirming its valuable role in O 2 monitoring of fibrin grafts. High ASC concentrations were found to increase human vessel area over time. The ability of ASCs to promote human neoangiogenesis by differentiation and growth factor secretion appears to be dependent on both cell concentration and time. We therefore conclude that ASCs loaded inside a fibrin scaffold at high concentrations could serve as a substrate to prepare the grafting site over 14 days, in order to enhance vascularization once human ovarian tissue is grafted. Our study constitutes an important first step towards improving the transplantation site for avascular grafting procedures by applying a novel technique that may some day be used for ovarian tissue transplantation. Future studies will need to investigate the effect of this approach on follicle survival rates and graft vascularization.
